Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29;39(1):254.
doi: 10.1007/s00383-023-05538-3.

Successful rescue pneumovesicoscopic surgery for post-Deflux® vesicoureteral junction obstruction

Affiliations

Successful rescue pneumovesicoscopic surgery for post-Deflux® vesicoureteral junction obstruction

Li-Yu Yang et al. Pediatr Surg Int. .

Abstract

Background: Vesicoureteral junction (VUJ) obstruction after Deflux® subureteral injection for vesicoureteral reflux (VUR) is rare and minimally invasive management has not been reported. This work investigated the patients who underwent Deflux® injection for VUR and identified those with subsequent VUJ obstruction.

Methods: Medical records of matched patients from October 2003 to March 2022 were reviewed, and parameters were retrospectively studied. All patients underwent Deflux® injection. The injection was performed under general anesthesia using the same manner. For patients complicated with VUJ obstruction, the symptoms, signs, management, images, renal ultrasounds, Tc-99m dimercaptosuccinic acid renal scintigraphy, histology of VUJ region, and outcomes were documented and reported. VUJ stenosis was diagnosed by performing renal ultrasound and magnetic resonance imaging.

Results: Totally 407 patients (554 ureterorenal units) received Dx/HA injections for VUR. VUJ obstruction was found in three patients (four ureterorenal units). Originally, three were grade V VUR, and one was grade IV. The repeated injection was not a risk factor for VUJ obstruction. The overall incidence of VUJ obstruction post-Dx/HA injection was 0.7% by ureter. The incidences were 0%, 0.75%, and 2.25% for grade I-III, IV, and V VUR, respectively. After the initial conversion case of pneumovesicoscopic ureteral reimplantation, the procedure was performed smoothly and successfully in the two following cases.

Conclusions: Pneumovesicoscopic ureteral reimplantation offers an alternative for VUJ obstruction following Dx/HA injection for VUR. Fibrosis and foreign-body reaction may influence the feasibility. High-grade VUR and young age of injection were related to VUJ obstruction.

Keywords: Dextranomer/hyaluronic acid; Pneumovesicoscopy; Ureteral reimplantation; Vesicoureteral junction obstruction; Vesicoureteral reflux.

PubMed Disclaimer

Similar articles

References

    1. Baydilli N, Selvi I, Pinarbasi AS et al (2021) Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux. J Pediatr Urol 17(1):68e1-68e8 - DOI
    1. Nordenstrom J, Holmdahl G, Brandstrom P et al (2017) The Swedish infant high-grade reflux trial: study presentation and vesicoureteral reflux outcome. J Pediatr Urol 13(2):130–138. https://doi.org/10.1016/j.jpurol.2016.08.026 - DOI - PubMed
    1. Puri P, Kutasy B, Colhoun E et al (2012) Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. J Urol 188(4 Suppl):1485–1489. https://doi.org/10.1016/j.juro.2012.02.023 - DOI - PubMed
    1. Coplen DE (2011) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. Yearb Urol 2011:207–208. https://doi.org/10.1016/j.yuro.2010.12.004 - DOI
    1. Tekgul S, Riedmiller H, Hoebeke P et al (2012) EAU guidelines on vesicoureteral reflux in children. Eur Urol 62(3):534–542. https://doi.org/10.1016/j.eururo.2012.05.059 - DOI - PubMed

LinkOut - more resources